These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Varicella vaccination in HIV-1-infected children after immune reconstitution. Bekker V, Westerlaken GH, Scherpbier H, Alders S, Zaaijer H, van Baarle D, Kuijpers T. AIDS; 2006 Nov 28; 20(18):2321-9. PubMed ID: 17117018 [Abstract] [Full Text] [Related]
24. Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005. Lin YH, Huang LM, Chang IS, Tsai FY, Chang LY. J Microbiol Immunol Infect; 2009 Feb 28; 42(1):5-12. PubMed ID: 19424552 [Abstract] [Full Text] [Related]
25. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan. Chang CK, Tan HF, Tseng HF, Lin CC. Med Mal Infect; 2007 Apr 28; 37(4):222-8. PubMed ID: 17368781 [Abstract] [Full Text] [Related]
26. The safety profile of varicella vaccine: a 10-year review. Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG. J Infect Dis; 2008 Mar 01; 197 Suppl 2():S165-9. PubMed ID: 18419392 [Abstract] [Full Text] [Related]
31. Is Europe ready to embrace a policy of universal varicella vaccination? Ramet J, Weil-Olivier C, Sedlak W, Confederation of the European Specialists of Paediatrics (CESP)/European Academy of Paediatrics (EAP) CESP/EAP. Int J Clin Pract; 2005 Nov 01; 59(11):1326-33. PubMed ID: 16236088 [Abstract] [Full Text] [Related]
32. Varicella vaccination in Australia and New Zealand. Macartney KK, Burgess MA. J Infect Dis; 2008 Mar 01; 197 Suppl 2():S191-5. PubMed ID: 18419396 [Abstract] [Full Text] [Related]
33. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age. Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ. Pediatr Infect Dis J; 2007 Jul 01; 26(7):572-6. PubMed ID: 17596796 [Abstract] [Full Text] [Related]
37. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine. Watson B. J Infect Dis; 2008 Mar 01; 197 Suppl 2():S143-6. PubMed ID: 18419388 [Abstract] [Full Text] [Related]
38. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1. Armenian SH, Han JY, Dunaway TM, Church JA. Pediatr Infect Dis J; 2006 Apr 01; 25(4):368-70. PubMed ID: 16567993 [Abstract] [Full Text] [Related]
40. Report of varicella outbreak in a low vaccination coverage group of otherwise healthy children in Italy: the role of breakthrough and the need of a second dose of vaccine. Tafuri S, Martinelli D, De Palma M, Germinario C, Prato R. Vaccine; 2010 Feb 10; 28(6):1594-7. PubMed ID: 19961965 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]